Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

75 trials with published results (28%)

Research Maturity

190 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.2%

14 terminated out of 271 trials

Success Rate

93.1%

+6.6% vs benchmark

Late-Stage Pipeline

31%

85 trials in Phase 3/4

Results Transparency

39%

75 of 190 completed with results

Key Signals

75 with results93% success14 terminated

Data Visualizations

Phase Distribution

239Total
Not Applicable (95)
Early P 1 (2)
P 1 (18)
P 2 (39)
P 3 (34)
P 4 (51)

Trial Status

Completed190
Unknown34
Recruiting14
Terminated14
Not Yet Recruiting8
Active Not Recruiting6

Trial Success Rate

93.1%

Benchmark: 86.5%

Based on 190 completed trials

Clinical Trials (271)

Showing 20 of 20 trials
NCT06220474Not ApplicableRecruitingPrimary

Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD

NCT05784519Early Phase 1Active Not Recruiting

Therapeutic Effect of Stem Cell Eye Drops on Dry Eye Disease

NCT04730336Not ApplicableCompleted

Assessing the Impact of Tixel Treatment of Periorbital Wrinkles on Dry Eye Symptoms and Signs

NCT06089317Not ApplicableCompletedPrimary

Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye Disease

NCT06388070Phase 3CompletedPrimary

To Evaluate the Efficacy and Safety of HUC3-053 in Patients With Dry Eye Syndrome

NCT07430137Not ApplicableNot Yet RecruitingPrimary

Blink Reminders and Meibomian Gland Loss in Digital Screen Users

NCT07415330Not ApplicableNot Yet Recruiting

Lacrima VR for Dry Eye Disease and Meibomian Gland Dysfunction

NCT07412860Not ApplicableRecruitingPrimary

Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED

NCT06483750Not ApplicableCompleted

Preoperative iLux on Cataract Surgery Derived Dry Eye Disease Due to Meibomian Gland Dysfunction

NCT06004895Not ApplicableCompletedPrimary

Mechanisms of Light-based Therapies for Dry Eye Disease

NCT01684852CompletedPrimary

Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution

NCT06163989Not ApplicableRecruitingPrimary

Protecting the Eyes of Gamers With Lubricating Eyedrops

NCT06371300Not ApplicableRecruitingPrimary

Photobiomodulation With REd vs BluE Light (REBEL)

NCT03697876Phase 1CompletedPrimary

Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel

NCT05653921SuspendedPrimary

Prospective Study to Validate the Imaging Biomarker for NCP (R33)

NCT04425551Not ApplicableCompleted

Effect of Micropulse Laser on Dry Eye Disease Due to Meibomian Gland Dysfunction

NCT03358979Recruiting

Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)

NCT07267481Phase 4Not Yet Recruiting

Switching From Xiidra to TRYPTYR

NCT03804502Not ApplicableCompletedPrimary

Pilot Study of TearCare System - Long-Term Extension

NCT03502447Not ApplicableTerminatedPrimary

Randomized Study of the Safety and Effectiveness of the TearCare System for the Signs and Symptoms of Dry Eye Disease

Scroll to load more

Research Network

Activity Timeline